The maker of Viagra, Lipitor and Advil has been slashing thousands of jobs since acquiring rival Wyeth in 2009.
Now, as several of its key products run out of patent protection, it is also downsizing its research and development spending.
The company plans to still cut another 5,530 employees -- or 5% of its global workforce. While many of those jobs cuts will come from the closure of a factory in Sandwich, England, they will also affect many U.S. employees who work in R&D roles.
These young job seekers graduated into the worst labor market since the Great Depression.
|Charter announces plan to buy Time Warner Cable and Bright House|
|Wealthy Chinese 'Star Trek' fan builds company headquarters in shape of USS Enterprise|
|What I wish I knew about money on graduation day|
|China gets a new billionaire every week|
|Tinder and hookup apps blamed for rise in STDs|